Restricted accessReview articleFirst published online 2023-1
Diagnostic performance of MRI and endoscopy for assessing complete response in rectal cancer after neoadjuvant chemoradiotherapy: a systematic review of the literature
The diagnostic performance of magnetic resonance imaging (MRI) modalities and/or endoscopy for assessing complete response in rectal cancer after neoadjuvant chemoradiotherapy (nCRT) is unclear.
Purpose
To summarize existing evidence on the diagnostic performance of diffusion-weighted MRI, perfusion-weighted MRI, T2-weighted MR tumor regression grade, and/or endoscopy for assessing complete tumor response after nCRT.
Material and Methods
MEDLINE and Embase databases were searched. The PRISMA guidelines were followed. Sensitivity, specificity, negative predictive, and positive predictive values were retrieved from included studies.
Results
In total, 81 studies were eligible for inclusion. Evidence suggests that combined use of MRI and endoscopy tends to improve the diagnostic performance compared to single imaging modality. The positive predictive value of a complete response varies substantially between studies. There is considerable heterogeneity between studies.
Conclusion
Combined re-staging tends to improve diagnostic performance compared to single imaging modality, but the vast majority of studies fail to offer true clinical value due to the study heterogeneity.
BraendengenMTveitKMBerglundA, et al.Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol2008;26:3687–3694.
2.
BülowSHarlingHIversenLH, et al.Improved survival after rectal cancer in Denmark. Colorectal Dis2010;12:e37–e42.
3.
BujkoKNowackiMPNasierowska-GuttmejerA, et al.Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg2006;93:1215–1223.
4.
PaunBCCassieSMacLeanAR, et al.Postoperative complications following surgery for rectal cancer. Ann Surg2010;251:807–818.
5.
HendrenSKO’ConnorBILiuM, et al.Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg2005;242:212–223.
6.
HarrisonJDSolomonMJYoungJM, et al.Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. Arch Surg2008;143:389–394.
7.
GameiroJFonsecaJANevesM, et al.Acute kidney injury in major abdominal surgery: incidence, risk factors, pathogenesis and outcomes. Ann Intensive Care2018;8:22.
8.
EngelJKerrJSchlesinger-RaabA, et al.Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg2003;238:203–213.
9.
MignanelliEDde Campos-LobatoLFStocchiL, et al.Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye?Dis Colon Rectum2010;53:251–256.
10.
MaasMNelemansPJValentiniV, et al.Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol2010;11:835–844.
11.
Habr-GamaAPerezRONadalinW, et al.Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg2004;240:711–718.
12.
MaasMBeets-TanRGLambregtsDM, et al.Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol2011;29:4633–4640.
13.
Beets-TanRGLambregtsDMMaasM, et al.Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol2018;28:1465–1475.
14.
ChenCCLeeRCLinJK, et al.How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?Dis Colon Rectum2005;48:722–728.
15.
MarettoIPomerriFPucciarelliS, et al.The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol2007;14:455–461.
16.
WynnGRBhasinNMacklinCP, et al.Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: opinions of British and Irish specialists. Colorectal Dis2010;12:327–333.
17.
PatelUBTaylorFBlomqvistL, et al.Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol2011;29:3753–3760.
18.
Beets-TanRGBeetsGL. MRI For assessing and predicting response to neoadjuvant treatment in rectal cancer. Nat Rev Gastro Hepat2014;11:480–488.
19.
MoherDLiberatiATetzlaffJ, et al.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol2009;62:1006–1012.
20.
Wille-JørgensenPRenehanAG. Systematic reviews and meta-analyses in coloproctology: interpretation and potential pitfalls. Colorectal Dis2008;10:21–32.
21.
MandardAMDalibardFMandardJC, et al.Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer1994;73:2680–2686.
22.
DworakOKeilholzLHoffmannA. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis1997;12:19–23.
23.
GalonsJPLope-PiedrafitaSDivijakJL, et al.Uncovering of intracellular water in cultured cells. Magn Reson Med2005;54:79–86.
24.
PadhaniARLiuGMu-KohD, et al.Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia2009;11:102–125.
25.
ChandramohanASiddiqiUMMittalR, et al.Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Radiol Open2020;7:100223.
26.
ChoMSKimHHanYD, et al.Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: results from a prospective study of 110 patients. Medicine (Baltimore)2019;98:e16614.
27.
JangJKLeeJLParkSH, et al.Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer. Br J Surg2018;105:1671–1679.
28.
LeeMAChoSHSeoAN, et al.Modified 3-point MRI-based tumor regression grade incorporating DWI for locally advanced rectal cancer. AJR Am J Roentgenol2017;209:1247–1255.
29.
SclafaniFBrownGCunninghamD, et al.Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer2017;117:1478–1485.
30.
Van Den BroekJJVan Der WolfFSLahayeMJ, et al.Accuracy of MRI in restaging locally advanced rectal cancer after preoperative chemoradiation. Dis Colon Rectum2017;60:274–283.
31.
RengoMPicchiaSMarziS, et al.Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. Oncotarget2017;8:114746–114755.
32.
YuJXuQSongJC, et al.The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol2017;27:1848–1857.
33.
BhodayJSmithFSiddiquiMR, et al.Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy. Dis Colon Rectum2016;59:925–933.
34.
FayazMSDemianGAFathallahWM, et al.Significance of magnetic resonance imaging-assessed tumor response for locally advanced rectal cancer treated with preoperative long-course chemoradiation. J Glob Oncol2016;2:216–221.
35.
PatelUBBrownGRuttenH, et al.Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol2012;19:2842–2852.
36.
KoHMChoiYHLeeJE, et al.Combination assessment of clinical complete response of patients with rectal cancer following chemoradiotherapy with endoscopy and magnetic resonance imaging. Ann Coloproctol2019;35:202–208.
37.
SantiagoIBarataMFigueiredoN, et al.The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer. Eur Radiol2020;30:224–238.
38.
JiaXZhangYWangY, et al.MRI For restaging locally advanced rectal cancer: detailed analysis of discrepancies with the pathologic reference standard. AJR Am J Roentgenol2019;213:1081–1090.
39.
MengYWanLZhangC, et al.The predictive value of pre-/postneoadjuvant chemoradiotherapy MRI characteristics for patient outcomes in locally advanced rectal cancer. Acad Radiol2020;27:e233–e243.
40.
NahasSCNahasCSRCamaGM, et al.Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer. Abdom Radiol (New York)2019;44:3632–3640.
41.
WanLZhangCZhaoQ, et al.Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Abdom Radiol (New York)2019;44:2978–2987.
42.
YoenHParkHEKimSH, et al.Prognostic value of tumor regression grade on MR in rectal rancer: a large-scale, single-center experience. Korean J Radiol2020;21:1065–1076.
43.
AkerMBooneDChandramohanA, et al.Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment. Abdom Radiol (New York)2018;43:3213–3219.
44.
BayramIBakirBKartalMG, et al.The role of MRI with diffusion-weighted imaging in restaging rectal cancers after neoadjuvant chemoradiotherapy. South African J Radiol2016;20:1–6.
45.
ChoiMHOhSNRhaSE, et al.Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging2016;44:212–220.
46.
FotiPVPriviteraGPianaS, et al.Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy. Eur J Radiol Open2016;3:145–152.
47.
SathyakumarKChandramohanAMasihD, et al.Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. Br J Radiol2016;89:20150328.
48.
BirlikBObuzFElibolFD, et al.Diffusion-weighted MRI and MR -volumetry- in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Magn Reson Imaging2015;33:201–212.
49.
ChoSHKimGCJangYJ, et al.Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response. Acta Radiol2015;56:1042–1050.
50.
CaiPQWuYPAnX, et al.Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol2014;24:2962–2970.
51.
GenovesiDFilipponeAAusili CèfaroG, et al.Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. Eur J Surg Oncol2013;39:1071–1078.
52.
HaHIKimAYYuCS, et al.Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy. Eur Radiol2013;23:3345–3353.
53.
SassenSde BooijMSosefM, et al.Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?Eur Radiol2013;23:3440–3449.
54.
IppolitoDMonguzziLGuerraL, et al.Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging2012;37:1032–1040.
55.
LambrechtMVandecaveyeVDe KeyzerF, et al.Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys2012;82:863–870.
56.
SongIKimSHLeeSJ, et al.Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol2012;85:577–586.
57.
Curvo-SemedoLLambregtsDMMaasM, et al.Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy – conventional MR volumetry versus diffusion-weighted MR imaging. Radiology2011;260:734–743.
58.
KimSHLeeJYLeeJM, et al.Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Eur Radiol2011;21:987–995.
59.
KimSHLeeJMHongSH, et al.Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology2009;253:116–125.
60.
Delli PizziACianciRGenovesiD, et al.Performance of diffusion-weighted magnetic resonance imaging at 3.0 T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy. Abdom Radiol2018;43:2221–2230.
61.
ChenYGChenMQGuoYY, et al.Apparent diffusion coefficient predicts pathology complete response of rectal cancer treated with neoadjuvant chemoradiotherapy. PLoS One2016;11:e0153944.
62.
IntvenMReerinkOPhilippensME. Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy. Strahlenther Onkol2013;189:117–122.
63.
LiJWangJPangJ, et al.Optimized parameters of diffusion-weighted MRI for prediction of the response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Biomed Res Int2019;2019:9392747.
64.
YangLQiuMXiaC, et al.Value of high-resolution DWI in combination with texture analysis for the evaluation of tumor response after preoperative chemoradiotherapy for locally advanced rectal cancer. AJR Am J Roentgenol2019;212:1–8.
65.
BakkeKMHoleKHDuelandS, et al.Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival. Acta Oncol2017;56:813–818.
66.
IannicelliEDi PietropaoloMPilozziE, et al.Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy. Abdom Radiol2016;41:1906–1917.
67.
JacobsLIntvenMvan LelyveldN, et al.Diffusion-weighted MRI for early prediction of treatment response on preoperative chemoradiotherapy for patients with locally advanced rectal cancer: a feasibility study. Ann Surg2016;263:522–528.
68.
MonguzziLIppolitoDBernasconiDP, et al.Locally advanced rectal cancer: value of ADC mapping in prediction of tumor response to radiochemotherapy. Eur J Radiol2013;82:234–240.
69.
JungSHHeoSHKimJW, et al.Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging. J Magn Reson Imaging2012;35:110–116.
70.
QuaiaEGennariAGRicciardiMC, et al.Value of percent change in tumoral volume measured at T2-weighted and diffusion-weighted MRI to identify responders after neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma. J Magn Reson Imaging2016;44:1415–1424.
71.
PetrilloAFuscoRPetrilloM, et al.Standardized index of shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol2015;25:1935–1945.
72.
BarbaroBVitaleRValentiniV, et al.Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys2012;83:594–599.
73.
LambregtsDMVandecaveyeVBarbaroB, et al.Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol2011;18:2224–2231.
74.
HorvatNVeeraraghavanHKhanM, et al.MR Imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology2018;287:833–843.
75.
TaralloNAngerettiMGBracchiE, et al.Magnetic resonance imaging in locally advanced rectal cancer: quantitative evaluation of the complete response to neoadjuvant therapy. Polish J Radiol2018;83:e600–e609.
76.
BlazicIMLilicGBGajicMM. Quantitative assessment of rectal cancer response to neoadjuvant combined chemotherapy and radiation therapy: comparison of three methods of positioning region of interest for ADC measurements at diffusion-weighted MR imaging. Radiology2017;282:418–428.
77.
De FeliceFMagnanteALMusioD, et al.Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Eur J Surg Oncol2017;43:1324–1329.
78.
HuFTangWSunY, et al.The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging. Oncotarget2017;8:75597–75606.
79.
ZhuHBZhangXYZhouXH, et al.Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: a prospective single-center study. J Magn Reson Imaging2017;46:175–183.
80.
CiolinaMCarusoDDe SantisD, et al.Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment. Radiol Med2019;124:331–338.
81.
GollubMJTongTWeiserM, et al.Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer. Eur Radiol2017;27:1605–1612.
82.
TongTSunYGollubMJ, et al.Dynamic contrast-enhanced MRI: use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. J Magn Reson Imaging2015;42:673–680.
83.
GantenMKSchuesslerMBäuerleT, et al.The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging. Cancer Imaging2013;13:548–556.
84.
LimJSKimDBaekSE, et al.Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol2012;22:1693–1700.
85.
PetrilloAFuscoRPetrilloM, et al.Standardized index of shape (DCE-MRI) and standardized uptake value (PET/CT): two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Oncotarget2017;8:8143–8153.
86.
De CeccoCNCiolinaMCarusoD, et al.Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. Abdom Radiol2016;41:1728–1735.
87.
IntvenMMonninkhofEMReerinkO, et al.Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer. Acta Oncol2015;54:1729–1736.
88.
KimSHLeeJMGuptaSN, et al.Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Magn Reson Imaging2014;40:730–737.
89.
IppolitoDDragoSGPecorelliA, et al.Role of dynamic perfusion magnetic resonance imaging in patients with local advanced rectal cancer. World J Gastroenterol2020;26:2657–2668.
90.
AttenbergerUOngMRathmannN, et al.mMRI at 3.0T as an evaluation tool of therapeutic response to neoadjuvant CRT in patients with advanced-stage rectal cancer. Anticancer Res2017;37:215–222.
91.
HötkerAMTarlintonLMazaheriY, et al.Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: a comparison of morphological, volumetric and functional MRI parameters. Eur Radiol2016;26:4303–4312.
92.
NieKShiLChenQ, et al.Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI. Clin Cancer Res2016;22:5256–5264.
93.
TjalmaJJKollerMLinssenMD, et al.Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer. Gut2020;69:406–410.
94.
ChinoAKonishiTOguraA, et al.Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy. Eur J Surg Oncol2018;44:1247–1253.
95.
GollubMJBlazicIFelderS, et al.Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer. Eur Radiol2019;29:1104–1113.
96.
MaasMLambregtsDMNelemansPJ, et al.Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Ann Surg Oncol2015;22:3873–3880.
97.
SmithFMWilandHMaceA, et al.Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum2014;57:311–315.
98.
AsogluOTokmakHBakirB, et al.The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: the evaluation of 66 cases. Eur J Surg Oncol2020;46:402–409.
99.
KawaiKIshiharaSNozawaH, et al.Prediction of pathological complete response using endoscopic findings and outcomes of patients who underwent watchful waiting after chemoradiotherapy for rectal cancer. Dis Colon Rectum2017;60:368–375.
100.
Lopez-LopezVAbrisquetaJLujanJ, et al.Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer. Saudi J Gastroenterol2016;22:148–153.
101.
OguraAChinoAKonishiT, et al.Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response. Int J Colorectal Dis2015;30:367–373.
102.
Garcia-AguilarJShiQThomasCR, et al.A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol2012;19:384–391.
103.
KuoLJChiouJFTaiCJ, et al.Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy?Int J Colorectal Dis2012;27:613–621.
104.
BenzoniECeratoFCojuttiA, et al.The predictive value of clinical evaluation of response to neoadjuvant chemoradiation therapy for rectal cancer. Tumori2005;91:401–405.
105.
HiotisSPWeberSMCohenAM, et al.Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg2002;194:131–136.
106.
HupkensBJMartensMHStootJH, et al.Quality of life in rectal cancer patients after chemoradiation: watch-and-wait policy versus standard resection – a matched-controlled study. Dis Colon Rectum2017;60:1032–1040.
107.
SmithJJStrombomPChowOS, et al. Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy. JAMA Oncol 2019;5:e185896.
108.
van der ValkMJHillingDEBastiaannetE, et al.Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the international watch & wait database (IWWD): an international multicentre registry study. Lancet2018;391:2537–2545.
109.
RicciardiRMadoffRDRothenbergerDA, et al.Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol2006;4:1522–1527.
110.
RomboutsAJAl-NajamiIAbbottNL, et al.Can we save the rectum by watchful waiting or transanal microsurgery following (chemo) radiotherapy versus total mesorectal excision for early rectal cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open2017;7:e019474.
111.
JangJKChoiSHParkSH, et al.MR Tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy. Eur Radiol2020;30:2312–2323.
112.
AmodeoSRosmanASDesiatoV, et al.MRI-based apparent diffusion coefficient for predicting pathologic response of rectal cancer after neoadjuvant therapy: systematic review and meta-analysis. AJR Am J Roentgenol2018;211:W205–W216.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
